Dupilumab reduces absenteeism in patients with moderate to severe atopic dermatitis: Pooled results from the LIBERTY AD SOLO clinical trials
Publication date
2020-11
Authors
de Bruin-Weller, Marjolein
Simpson, Eric L
Cork, Michael
Chen, Zhen
Msihid, Jerome
Taniou, Christine
Eckert, Laurent
Gadkari, Abhijit
Bégo-Le Bagousse, Gaëlle
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by
Abstract
Keywords
Journal Article
Citation
de Bruin-Weller, M, Simpson, E L, Cork, M, Chen, Z, Msihid, J, Taniou, C, Eckert, L, Gadkari, A & Bégo-Le Bagousse, G 2020, 'Dupilumab reduces absenteeism in patients with moderate to severe atopic dermatitis : Pooled results from the LIBERTY AD SOLO clinical trials', Journal of the American Academy of Dermatology, vol. 83, no. 5, pp. 1499-1501. https://doi.org/10.1016/j.jaad.2020.05.142